WO2008117814A1 - 大腸送達用経口製剤 - Google Patents

大腸送達用経口製剤 Download PDF

Info

Publication number
WO2008117814A1
WO2008117814A1 PCT/JP2008/055652 JP2008055652W WO2008117814A1 WO 2008117814 A1 WO2008117814 A1 WO 2008117814A1 JP 2008055652 W JP2008055652 W JP 2008055652W WO 2008117814 A1 WO2008117814 A1 WO 2008117814A1
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical preparation
oral pharmaceutical
colon
drug
specific delivery
Prior art date
Application number
PCT/JP2008/055652
Other languages
English (en)
French (fr)
Inventor
Hiroyuki Kubo
Original Assignee
Teikoku Seiyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Co., Ltd. filed Critical Teikoku Seiyaku Co., Ltd.
Priority to AU2008230364A priority Critical patent/AU2008230364A1/en
Priority to US12/450,438 priority patent/US20100209520A1/en
Priority to CA002684655A priority patent/CA2684655A1/en
Priority to CN200880017544A priority patent/CN101677958A/zh
Priority to JP2009506354A priority patent/JPWO2008117814A1/ja
Priority to EP08738876.5A priority patent/EP2143424A4/en
Publication of WO2008117814A1 publication Critical patent/WO2008117814A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

　本発明は、優れた大腸への薬物送達能を有する経口製剤に関し、より詳しくは、本発明は、薬物を大腸に送達するための経口製剤であって、薬学的に許容可能な賦形剤から少なくともなる核と、該核を被覆する、薬物を含む内層と、該内層を被覆する、ｐＨ６．６以下で溶解または膨潤しうる陽イオン性ポリマーを含む中間層と、該中間層を被覆する、ｐＨ７．０以上で溶解しうる陰イオン性ポリマーを含む外層とを含んでなる、経口製剤に関する。
PCT/JP2008/055652 2007-03-26 2008-03-26 大腸送達用経口製剤 WO2008117814A1 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2008230364A AU2008230364A1 (en) 2007-03-26 2008-03-26 Oral pharmaceutical preparation for colon-specific delivery
US12/450,438 US20100209520A1 (en) 2007-03-26 2008-03-26 Oral pharmaceutical preparation for colon-specific delivery
CA002684655A CA2684655A1 (en) 2007-03-26 2008-03-26 Oral pharmaceutical preparation for colon-specific delivery
CN200880017544A CN101677958A (zh) 2007-03-26 2008-03-26 用于结肠-特异性递送的口服药物制剂
JP2009506354A JPWO2008117814A1 (ja) 2007-03-26 2008-03-26 大腸送達用経口製剤
EP08738876.5A EP2143424A4 (en) 2007-03-26 2008-03-26 ORAL PHARMACEUTICAL PREPARATION FOR SPECIFIC DELIVERY TO THE COLON

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90723007P 2007-03-26 2007-03-26
US60/907,230 2007-03-26

Publications (1)

Publication Number Publication Date
WO2008117814A1 true WO2008117814A1 (ja) 2008-10-02

Family

ID=39788547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/055652 WO2008117814A1 (ja) 2007-03-26 2008-03-26 大腸送達用経口製剤

Country Status (8)

Country Link
US (1) US20100209520A1 (ja)
EP (1) EP2143424A4 (ja)
JP (1) JPWO2008117814A1 (ja)
KR (1) KR20090122489A (ja)
CN (1) CN101677958A (ja)
AU (1) AU2008230364A1 (ja)
CA (1) CA2684655A1 (ja)
WO (1) WO2008117814A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014529630A (ja) * 2011-09-07 2014-11-13 ザウラー−ブロシュ、ローラント 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤
JP2016517425A (ja) * 2013-03-14 2016-06-16 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
JP2020534290A (ja) * 2017-09-20 2020-11-26 ティロッツ ファーマ アーゲーＴｉｌｌｏｔｔｓ Ｐｈａｒｍａ Ａｇ 溶液／懸濁液層状化による抗体を含む固形剤形の調製
JP2022503581A (ja) * 2018-08-24 2022-01-12 ドクトル ファルク ファルマ ゲーエムベーハー 有効成分を遠位結腸で遅延放出する多層構造ペレット剤

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
AU2013240289B2 (en) * 2012-03-29 2018-01-25 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
JOP20200144A1 (ar) 2012-04-30 2017-06-16 Tillotts Pharma Ag تركيبة عقار ذو إطلاق متأخر
EP3062776A1 (en) 2013-10-29 2016-09-07 Tillotts Pharma AG A delayed release drug formulation
US10182993B2 (en) 2015-04-06 2019-01-22 Patheon Softgels Inc. Compositions for colonic delivery of drugs
US9707182B2 (en) 2015-09-11 2017-07-18 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical dosage forms of budesonide
US20190111001A1 (en) * 2016-03-30 2019-04-18 University Of Maryland, Baltimore Microparticulate system for colonic drug delivery
US20180272042A1 (en) * 2017-03-22 2018-09-27 Brown University Drug-polymer film for controlled local delivery at tissue-device interface
KR102336720B1 (ko) * 2017-08-03 2021-12-08 주식회사 씨티씨바이오 유산균을 함유하는 장용성 과립 및 이의 제조방법
KR20200084329A (ko) 2017-11-03 2020-07-10 디에스엠 아이피 어셋츠 비.브이. 신규한 전달 체계
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JPS63301816A (ja) * 1987-01-29 1988-12-08 Takeda Chem Ind Ltd 有核顆粒およびその製造法
WO1994010983A1 (en) * 1992-11-06 1994-05-26 Hisamitsu Pharmaceutical Co., Inc. Peroral pharmaceutical preparation releasable in lower digestive tract
JPH0710745A (ja) * 1993-06-22 1995-01-13 Tanabe Seiyaku Co Ltd 放出開始時間制御型腸デリバリー経口製剤
JP2821952B2 (ja) 1992-11-06 1998-11-05 久光製薬株式会社 下部消化管放出性の経口医薬製剤
JP2967492B2 (ja) 1989-05-11 1999-10-25 中外製薬株式会社 腸内適所放出経口製剤
JP3185206B2 (ja) 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
JP2002080398A (ja) * 2000-07-14 2002-03-19 Roberto Valducci ｐＨに依存する多相的な放出を伴う経口用の固体の薬学的組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
SE8903914D0 (sv) * 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
JP3469926B2 (ja) * 1993-11-04 2003-11-25 太田製薬株式会社 大腸内放出型医薬製剤用粒状物
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
US20030158097A1 (en) * 2000-03-02 2003-08-21 Norifumi Tanida P-glycoprotein modifier-containing medicinal compositions to be delivered to the large intestine
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
US20010045964A1 (en) * 2000-04-25 2001-11-29 Microsoft Corporation Method and system for transferring images from an imaging source device toa destination
JP2003201256A (ja) * 2001-12-28 2003-07-18 Hisamitsu Pharmaceut Co Inc 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
DE10214002A1 (de) * 2002-03-27 2003-10-09 Roehm Gmbh Pharmazeutische Formulierung für den Wirkstoff Budesonid
JP2005097126A (ja) * 2003-09-22 2005-04-14 Tanabe Seiyaku Co Ltd 経口投与用ジルチアゼム製剤

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JPS63301816A (ja) * 1987-01-29 1988-12-08 Takeda Chem Ind Ltd 有核顆粒およびその製造法
JP2967492B2 (ja) 1989-05-11 1999-10-25 中外製薬株式会社 腸内適所放出経口製剤
WO1994010983A1 (en) * 1992-11-06 1994-05-26 Hisamitsu Pharmaceutical Co., Inc. Peroral pharmaceutical preparation releasable in lower digestive tract
JP2821952B2 (ja) 1992-11-06 1998-11-05 久光製薬株式会社 下部消化管放出性の経口医薬製剤
JPH0710745A (ja) * 1993-06-22 1995-01-13 Tanabe Seiyaku Co Ltd 放出開始時間制御型腸デリバリー経口製剤
JP3185206B2 (ja) 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
JP2002080398A (ja) * 2000-07-14 2002-03-19 Roberto Valducci ｐＨに依存する多相的な放出を伴う経口用の固体の薬学的組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2143424A4

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014529630A (ja) * 2011-09-07 2014-11-13 ザウラー−ブロシュ、ローラント 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤
JP2018065846A (ja) * 2011-09-07 2018-04-26 ザウラー−ブロシュ、ローラント 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤
JP2016517425A (ja) * 2013-03-14 2016-06-16 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
JP2019077705A (ja) * 2013-03-14 2019-05-23 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
JP2020534290A (ja) * 2017-09-20 2020-11-26 ティロッツ ファーマ アーゲーＴｉｌｌｏｔｔｓ Ｐｈａｒｍａ Ａｇ 溶液／懸濁液層状化による抗体を含む固形剤形の調製
JP7204743B2 (ja) 2017-09-20 2023-01-16 ティロッツ ファーマ アーゲー 溶液／懸濁液層状化による抗体を含む固形剤形の調製
JP2023036901A (ja) * 2017-09-20 2023-03-14 ティロッツ ファーマ アーゲー 溶液／懸濁液層状化による抗体を含む固形剤形の調製
JP2022503581A (ja) * 2018-08-24 2022-01-12 ドクトル ファルク ファルマ ゲーエムベーハー 有効成分を遠位結腸で遅延放出する多層構造ペレット剤
JP7374992B2 (ja) 2018-08-24 2023-11-07 ドクトル ファルク ファルマ ゲーエムベーハー 有効成分を遠位結腸で遅延放出する多層構造ペレット剤

Also Published As

Publication number Publication date
CA2684655A1 (en) 2008-10-02
EP2143424A4 (en) 2013-07-31
EP2143424A1 (en) 2010-01-13
KR20090122489A (ko) 2009-11-30
JPWO2008117814A1 (ja) 2010-07-15
CN101677958A (zh) 2010-03-24
US20100209520A1 (en) 2010-08-19
AU2008230364A1 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
WO2008117814A1 (ja) 大腸送達用経口製剤
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
WO2009088414A3 (en) Oral pharmaceutical dosage forms
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
WO2008120207A3 (en) Compositions for nasal delivery
WO2007121913A3 (en) Pharmaceutical solution formulations for pressurised metered dose inhalers
WO2011084618A3 (en) Compositions and methods for oral drug delivery
WO2012091523A3 (en) Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
AU2007295179A1 (en) Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
WO2009008001A3 (en) Inhalation device
IL192104A (en) Formulation suitable for subcutaneous administration containing molecules of ctla4ig, sugar and liquid liquid pharmacist acceptable and its use in drug preparation
FR2909867B3 (fr) Capsule remplie d'un medicament, en particulier d'un medicament inhalable.
WO2012022919A3 (fr) Formulations à base de nalbuphine et leurs utilisations
WO2012010669A3 (de) Arzneimittel zur oralen verabreichung umfassend ein gemisch aus silodosin und einem basischen copolymer
WO2006040779A3 (en) Controlled release gastric floating matrix formulation containing imatinib
IL195931A (en) Oral Pharmaceutical Preparation with Controlled Release of Active Ingredient and Methods of Manufacturing
ZA201004685B (en) Drug delivery system for administration of poorly water soluble pharmaceutically active substances
HRP20181517T1 (hr) Sustav dostave lijeka za administraciju u vodi topljive, kationske i amfifilne farmaceutski aktivne tvari
WO2006008173A3 (en) Pharmaceutical formulations for inhalation
WO2006060325A3 (en) Coated drug delivery formulations
WO2010098627A3 (ko) 약제학적 제제
EP2150235A4 (en) Capsule formulation coated with nanoparticles for the purpose of dermal drug administration
EP2206519A4 (en) MEDICINAL PREPARATION FOR ORAL ADMINISTRATION
EP2231192A4 (en) DRUG DISPENSING SYSTEM FOR THE ADMINISTRATION OF A WATER-SOLUBLE, CATIONIC AND AMPHIPHILIC PHARMACEUTICAL ACTIVE SUBSTANCE

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880017544.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08738876

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009506354

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2684655

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 20097022139

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2008230364

Country of ref document: AU

Ref document number: 6793/DELNP/2009

Country of ref document: IN

Ref document number: 2008738876

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2008230364

Country of ref document: AU

Date of ref document: 20080326

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12450438

Country of ref document: US